XORIMAX

This brand name is authorized in Ecuador, Estonia, Hong Kong, Croatia, Lithuania, Poland, Singapore

Active ingredients

The drug XORIMAX contains one active pharmaceutical ingredient (API):

1 Cefuroxime UNII Z49QDT0J8Z - CEFUROXIME AXETIL

Cefuroxime inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs). This results in the interruption of cell wall (peptidoglycan) biosynthesis, which leads to bacterial cell lysis and death. Read about Cefuroxime

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01DC02	Cefuroxime	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DC Second-generation cephalosporins
Discover more medicines within J01DC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 29403-10-10, 29657-02-11
Country: EE	Ravimiamet	Identifier(s): 1219755, 1219766, 1219777, 1219788, 1219799, 1219801, 1219812, 1219823, 1624801
Country: HK	Department of Health Drug Office	Identifier(s): 58622, 58709
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-230586705, HR-H-684676442
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1004311, 1017583, 1017584, 1017585, 1022056, 1022057, 1052441, 1052443, 1069688, 1081774, 1081775
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100139841, 100140465, 100335401, 100342170, 100365891
Country: SG	Health Sciences Authority	Identifier(s): 13287P